vs
ANAPTYSBIO, INC（ANAB）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
ANAPTYSBIO, INC的季度营收约是RE/MAX Holdings, Inc.的1.5倍（$108.2M vs $71.1M），ANAPTYSBIO, INC净利率更高（45.8% vs 2.0%，领先43.8%），ANAPTYSBIO, INC同比增速更快（151.1% vs -1.8%），ANAPTYSBIO, INC自由现金流更多（$98.0M vs $33.5M），过去两年ANAPTYSBIO, INC的营收复合增速更高（288.3% vs -4.7%）
AnaptysBio是一家处于临床阶段的生物技术企业，专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法，主要面向美国市场，推进创新候选药物管线研发以满足未被满足的临床需求。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
ANAB vs RMAX — 直观对比
营收规模更大
ANAB
是对方的1.5倍
$71.1M
营收增速更快
ANAB
高出152.9%
-1.8%
净利率更高
ANAB
高出43.8%
2.0%
自由现金流更多
ANAB
多$64.5M
$33.5M
两年增速更快
ANAB
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $108.2M | $71.1M |
| 净利润 | $49.6M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | 61.8% | 13.1% |
| 净利率 | 45.8% | 2.0% |
| 营收同比 | 151.1% | -1.8% |
| 净利润同比 | 327.8% | -75.2% |
| 每股收益（稀释后） | $1.64 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANABRMAX
| Q4 25 | $108.2M | $71.1M | ||
| Q3 25 | $76.3M | $73.2M | ||
| Q2 25 | $22.3M | $72.8M | ||
| Q1 25 | $27.8M | $74.5M | ||
| Q4 24 | $43.1M | $72.5M | ||
| Q3 24 | $30.0M | $78.5M | ||
| Q2 24 | $11.0M | $78.5M | ||
| Q1 24 | $7.2M | $78.3M |
净利润ANABRMAX
| Q4 25 | $49.6M | $1.4M | ||
| Q3 25 | $15.1M | $4.0M | ||
| Q2 25 | $-38.6M | $4.7M | ||
| Q1 25 | $-39.3M | $-2.0M | ||
| Q4 24 | $-21.8M | $5.8M | ||
| Q3 24 | $-32.9M | $966.0K | ||
| Q2 24 | $-46.7M | $3.7M | ||
| Q1 24 | $-43.9M | $-3.4M |
营业利润率ANABRMAX
| Q4 25 | 61.8% | 13.1% | ||
| Q3 25 | 45.5% | 25.0% | ||
| Q2 25 | -117.5% | 19.3% | ||
| Q1 25 | -99.2% | 7.2% | ||
| Q4 24 | -22.4% | 5.9% | ||
| Q3 24 | -75.8% | 19.4% | ||
| Q2 24 | -367.5% | 20.6% | ||
| Q1 24 | -587.8% | 5.8% |
净利率ANABRMAX
| Q4 25 | 45.8% | 2.0% | ||
| Q3 25 | 19.8% | 5.4% | ||
| Q2 25 | -173.5% | 6.4% | ||
| Q1 25 | -141.6% | -2.6% | ||
| Q4 24 | -50.5% | 8.0% | ||
| Q3 24 | -109.4% | 1.2% | ||
| Q2 24 | -425.3% | 4.7% | ||
| Q1 24 | -612.0% | -4.3% |
每股收益（稀释后）ANABRMAX
| Q4 25 | $1.64 | — | ||
| Q3 25 | $0.52 | — | ||
| Q2 25 | $-1.34 | — | ||
| Q1 25 | $-1.28 | — | ||
| Q4 24 | $-0.63 | — | ||
| Q3 24 | $-1.14 | — | ||
| Q2 24 | $-1.71 | — | ||
| Q1 24 | $-1.64 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $37.2M | $452.4M |
| 总资产 | $364.4M | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资ANABRMAX
| Q4 25 | $238.2M | $118.7M | ||
| Q3 25 | $109.8M | $107.5M | ||
| Q2 25 | $44.3M | $94.3M | ||
| Q1 25 | $98.6M | $89.1M | ||
| Q4 24 | $123.1M | $96.6M | ||
| Q3 24 | $191.6M | $83.8M | ||
| Q2 24 | $71.8M | $66.1M | ||
| Q1 24 | $53.7M | $82.1M |
总债务ANABRMAX
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
股东权益ANABRMAX
| Q4 25 | $37.2M | $452.4M | ||
| Q3 25 | $-29.4M | $448.1M | ||
| Q2 25 | $-44.7M | $442.4M | ||
| Q1 25 | $34.0M | $433.5M | ||
| Q4 24 | $70.9M | $429.5M | ||
| Q3 24 | $84.4M | $423.1M | ||
| Q2 24 | $9.9M | $418.4M | ||
| Q1 24 | $47.8M | $412.0M |
总资产ANABRMAX
| Q4 25 | $364.4M | $582.5M | ||
| Q3 25 | $353.1M | $582.2M | ||
| Q2 25 | $335.3M | $574.8M | ||
| Q1 25 | $422.1M | $571.4M | ||
| Q4 24 | $483.8M | $581.6M | ||
| Q3 24 | $493.4M | $578.6M | ||
| Q2 24 | $427.4M | $571.4M | ||
| Q1 24 | $405.8M | $566.7M |
负债/权益比ANABRMAX
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | $33.5M |
| 自由现金流率自由现金流/营收 | 90.5% | 47.1% |
| 资本支出强度资本支出/营收 | 0.0% | 10.4% |
| 现金转化率经营现金流/净利润 | 1.98× | 28.39× |
| 过去12个月自由现金流最近4个季度 | $19.6M | $56.8M |
8季度趋势，按日历期对齐
经营现金流ANABRMAX
| Q4 25 | $98.0M | $40.9M | ||
| Q3 25 | $-27.4M | $17.7M | ||
| Q2 25 | $-40.2M | $4.6M | ||
| Q1 25 | $-10.7M | $5.7M | ||
| Q4 24 | $-66.7M | $59.7M | ||
| Q3 24 | $-10.1M | $17.6M | ||
| Q2 24 | $-21.3M | $15.9M | ||
| Q1 24 | $-37.3M | $9.4M |
自由现金流ANABRMAX
| Q4 25 | $98.0M | $33.5M | ||
| Q3 25 | $-27.4M | $16.4M | ||
| Q2 25 | $-40.3M | $2.9M | ||
| Q1 25 | $-10.7M | $4.0M | ||
| Q4 24 | $-66.9M | $53.0M | ||
| Q3 24 | $-10.1M | $16.3M | ||
| Q2 24 | $-21.4M | $14.0M | ||
| Q1 24 | $-37.3M | $6.8M |
自由现金流率ANABRMAX
| Q4 25 | 90.5% | 47.1% | ||
| Q3 25 | -35.9% | 22.4% | ||
| Q2 25 | -180.9% | 4.0% | ||
| Q1 25 | -38.7% | 5.3% | ||
| Q4 24 | -155.3% | 73.2% | ||
| Q3 24 | -33.7% | 20.8% | ||
| Q2 24 | -194.6% | 17.8% | ||
| Q1 24 | -519.3% | 8.6% |
资本支出强度ANABRMAX
| Q4 25 | 0.0% | 10.4% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.2% | 2.2% | ||
| Q1 25 | 0.1% | 2.3% | ||
| Q4 24 | 0.6% | 9.1% | ||
| Q3 24 | 0.1% | 1.7% | ||
| Q2 24 | 0.3% | 2.4% | ||
| Q1 24 | 0.4% | 3.3% |
现金转化率ANABRMAX
| Q4 25 | 1.98× | 28.39× | ||
| Q3 25 | -1.81× | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANAB
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
